Natixis Advisors’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$811K Buy
23,418
+6,680
+40% +$179K ﹤0.01% 1562
2026
Q1
$347K Buy
+16,738
New +$395K ﹤0.01% 1624
2025
Q4
Sell
-20,433
Closed -$1.16M 1656
2025
Q3
$1.16M Sell
20,433
-285
-1% -$14.6K ﹤0.01% 1266
2025
Q2
$1.03M Buy
+20,718
New +$936K ﹤0.01% 1290
2025
Q1
Sell
-25,523
Closed -$617K 1637
2024
Q4
$617K Buy
+25,523
New +$632K ﹤0.01% 1424

Other funds holding HIMS

Natixis Advisors's HIMS Position: Q2 2026 in Review

Natixis Advisors increased its Hims & Hers Health (HIMS) stake by 40% in Q2 2026, buying an estimated $179K and bringing the position to 23,418 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #1562.

Natixis Advisors first reported a position in HIMS in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.16M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Natixis Advisors held 23,418 shares of Hims & Hers Health worth $811K as of Q2 2026.
  • Natixis Advisors bought 6,680 Hims & Hers Health shares in Q2 2026, an estimated $179K.
  • Hims & Hers Health made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1562 holding.
  • Natixis Advisors first reported a position in Hims & Hers Health in Q4 2024 and has held it in 5 quarters since.
  • Natixis Advisors's Hims & Hers Health position peaked at $1.16M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.